HealthLumen are specialists in precision epidemiology. Our solutions are centered around quantifying the current and future burden of rare genetic and non-communicable diseases and generating data-driven evidence to support decision-making at each stage of the drug development lifecycle, helping to accelerate patient access to therapies.

We combine our powerful genetic database mining and microsimulation modelling methodologies to provide robust estimates of patient population sizes and project the future health and economic impacts of proposed interventions before real-world implementation.

Case Studies: https://www.healthlumen.com/case_study/
Publications: https://www.healthlumen.com/publications/